… medications such as sibutramine and topiramate. The combination of these two drugs … the Department of Pharmacological Treatment at the Brazilian … “For patients who develop hypertension or tachycardia, … in patients with coronary artery disease, prior stroke, …

… diagnosis and treatment.7 Current treatment primarily consists … , skin therapy, program development management, and patient advocacy … -management program on medication adherence of epileptic … for patients with coronary heart disease: a systematic review …

… multicenter, single-arm phase 2 trial (NCT05795920) revealed that 20 … active heart disease, including systemic coronary heart disease, and severe uncontrolled recurrent … The FDA granted orphan drug designation to Biostar Pharma’s utidelone for the treatment …

Here are six cardiologists making moves in the last 10 days: 1. Terre Haute, Ind.-based Union Health added Dr. Irfan Shafi, MD, to its team. Dr. Shafi is a cardiologist with clinical interests in angiography, acute coronary syndromes and coronary artery …

… and Urologic Drugs Advisory Committee or the Drug Safety and … of these medications for the prevention, but not treatment, of … for the prevention of coronary heart disease.[17] The boxed warning … supported by pharmaceutical companies.[22] The FDA expert panel …

… earlier diagnosis, sharper treatment planning and safer … all cardiovascular diseases including coronary artery disease (CAD), hypertension, heart … even before they develop. Such tests reveal … treatment.  In addition to traditional therapies, drugs …

… marks the latest positive development for Heartflow after the … it as the only FDA-cleared, AI-powered plaque … to enable rapid assessment of coronary artery disease (CAD) location and severity … risk and guiding personalized treatment,” said Dr. Matthew Budoff …

… most transformative medicines ever developed, one would quickly … s drug candidate, which is in a phase 1b trial, … coronary artery disease is the leading killer of humans.” A one-and-done treatment … a clinical trial in its program for treating chronic hepatitis …

… secured the US Food and Drug Administration (FDA) 510(k) clearance for … technology is said to enhance coronary artery disease (CAD) diagnosis with an improved … Analysis tool is the only FDA-approved AI-powered plaque quantification …

… threatening health issues (including coronary heart disease, heart attack, and stroke … often treated with significant pharmacological and/or … unnecessary and potentially harmful treatments. Today's … and other providers treating conditions related to …